Together, these data support that GPX7 overexpression may be involved in glioma tumorigenesis, which appears to be differentially regulated by molecular mechanisms during the progression of the cell cycle, perhaps being modulated by various factors of the tumor microenvironment, especially in response to exposure to oxidative stress (ROS accumulation). Here, GPX7 is linked to central nervous system cancer.